The New York Times
Prof. Jonathan Weissman speaks with The New York Times’ Emily Baumgaertner Nunn about epigenome editing, including a single injection that would silence a gene in the liver that destroys receptors responsible for clearing LDL cholesterol. “This is sort of the ultimate one-and-done treatment,” says Weissman. “I don’t think we know enough to be able to do it at the moment, but it is not so far off from what’s imaginable.”